Chemedix India Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 50.00 K
- Company Age 5 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 313.83%
- Profit Growth 230.84%
- Ebitda 229.03%
- Net Worth 607.53%
- Total Assets 97.26%
About Chemedix India
Chemedix India Private Limited (CIPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 18 April 2019 (Five years and nine months 23 days old ). Its registered office is in Jalgaon, Maharashtra, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 50.00 K , as per Ministry of Corporate Affairs (MCA) records.
Bhushan Gurav, Tosifkhan Mevati, and Vishal Khadke serve as directors at the Company.
Company Details
-
Location
Jalgaon, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999MH2019PTC324202
-
Company No.
324202
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
18 Apr 2019
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Chemedix India?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhushan Gurav
|
Director | 18-Apr-2019 | Current |
|
Tosifkhan Mevati
|
Director | 18-Apr-2019 | Current |
|
Vishal Khadke
|
Director | 18-Apr-2019 | Current |
Financial Performance of Chemedix India.
Chemedix India Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 313.83% increase. The company also saw a substantial improvement in profitability, with a 230.84% increase in profit. The company's net worth Soared by an impressive increase of 607.53%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chemedix India?
In 2021, Chemedix India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Verodox Healthcare Private LimitedBhushan Gurav is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Chemedix India?
Unlock and access historical data on people associated with Chemedix India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chemedix India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chemedix India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.